The Neuroendocrine Tumor Research Foundation announced its newest neuroendocrine cancer research grant recipients. The 10 investigators receiving awards are studying the most promising scientific approaches to understanding and treating neuroendocrine cancer. Funding for these ten grants totals $2 million, bringing NETRF’s all-time investment in research to $39.8 million. Elyse Gellerman, NETRF’s chief executive officer, thanked the many individuals and foundations whose financial support helps to fund NETRF’s research and education programs including Katherine’s Light Foundation.